Brunn Carsten 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Brunn Carsten
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-01-03$16.72/sh−8,563$143,190→ 212,804 total - Sale
Common Stock
2025-01-06$16.83/sh−8,708$146,575→ 204,096 total
Footnotes (1)
- [F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.